Apellis Pharmaceuticals, Inc. (APLS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$41.030.00%
Close 2026-05-14 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · APLS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenues | 1,105.3 | 1,003.8 | 781.4 | 396.6 | 75.4 | 66.6 | 250.6 | — | — | — |
| Operating Expenses & Income | ||||||||||
| Selling, General & Admin | 545.2 | 550.3 | 501.1 | 500.8 | 277.2 | — | — | — | — | — |
| R&D Expenses | 286.4 | 295.9 | 327.6 | 354.4 | 387.2 | 345.9 | 299.9 | 221.0 | 105.3 | — |
| Operating Income | 165.2 | 55.4 | (165.0) | (517.1) | (594.6) | (536.3) | (213.7) | (288.0) | (127.9) | (50.8) |
| Earnings from Continuing Operations | ||||||||||
| Interest Expense | — | 44.3 | 40.4 | — | — | — | — | — | — | — |
| Interest & Investment Income | 13.4 | 13.1 | 12.8 | 20.9 | 8.9 | 0.4 | 4.2 | 5.1 | 3.0 | — |
| EBT, Incl. Unusual Items | 135.1 | 24.1 | (196.7) | (526.5) | (651.5) | (746.0) | (343.0) | (304.7) | — | — |
| Income Tax Expense | 1.9 | 1.7 | 1.2 | 2.1 | 0.7 | 0.4 | 1.8 | — | — | — |
| Net Income | ||||||||||
| Net Income | 133.3 | 22.4 | (197.9) | (528.6) | (652.2) | (746.4) | (344.9) | (304.7) | (127.5) | (51.0) |
| Per Share | ||||||||||
| Basic EPS | 1.04 | 0.18 | (1.60) | (4.45) | (6.15) | (8.84) | (4.59) | — | — | — |
| Diluted EPS | 1.01 | 0.20 | (1.60) | (4.45) | (6.15) | (8.84) | (4.59) | — | — | — |
| Revenue per Share | 8.41 | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 127.7 | 126.1 | 123.9 | 118.7 | 106.1 | 84.4 | 75.2 | — | — | — |
| Diluted Weighted Avg Shares | 131.4 | 129.9 | 123.9 | 118.7 | 106.1 | 84.4 | 75.2 | — | — | — |
| Supplemental | ||||||||||
| EBIT | 165.2 | 55.4 | (165.0) | (517.1) | (594.6) | (536.3) | (213.7) | (288.0) | (127.9) | (50.8) |
| Effective Tax Rate | 1.4% | — | — | -0.4% | -0.1% | -0.0% | -0.5% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.